Jilin University Sino Japanese Friendship Hospital nuclear medicine discipline
views：time：2018-03-08 16:28:07
The nuclear medicine discipline of the Sino Japanese Friendship Hospital of Jilin University (the original Bethune Medical College) has developed into a modern comprehensive Department of medical science, teaching and scientific research since its establishment in 1958. The available area of the Department is more than 1000 square meters. The medical, technical and nursing staff of the Department are fully equipped. More than 30 people were employed and employed, of which 9 were medical series: 1 doctorate tutors, 2 master's tutors, 6 doctors in doctors (3 in reading), 75%, and 2 of the master's degree, accounting for 25%.
The whole branch nuclide treatment group, molecular imaging diagnosis group and in vitro molecular detection group have unique medical characteristics. The new technology, new equipment, new methods and new experiences are applied to the clinic, and some diagnosis and treatment technologies are in the forefront of Jilin province and the whole country. It is well known in the province and in the country. It has become a training base for provincial nuclear medical talents, and was approved as a master degree subject in 1985. In 1996, it is a PhD authorization subject. There are more than ten doctoral students and more than ten master's students. The Department is the main Committee of the nuclear medical branch of Jilin province. In 2013, it was appraised as the national key specialist construction project. It is a member of the multi-disciplinary diagnosis and treatment center of thyroid disease in Jilin.
The Molecular Imaging Diagnostic Team (MIDG) has carried out a comprehensive project with advanced technology, ranking in the forefront of the country, with an annual inspection of more than 10,000 people. We have dual probe SPECT, SPECT/CT and dual energy X-ray absorptiometry. The latest 99mTc-RG is the latest 99mTc-RG, including bone scintigraphy, thyroid imaging, parathyroid imaging, parathyroid imaging, myocardial imaging, renal dynamic imaging, lung perfusion and lung ventilation imaging, dynamic imaging of salivary glands, lymphosinography, gastrointestinal bleeding imaging, ectopic gastric mucosa imaging, and lower limb static pulse imaging. D-tumor receptor imaging, 99mTc-TF tumor molecule imaging, octreotide receptor imaging, 99mTc-HL91 hypoxia imaging and so on have realized the monitoring of individual medical effect.
The radionuclide treatment group has rich experience in radionuclide therapy and is one of the largest bases of radionuclide therapy in the province. It has the first radionuclide treatment ward in the province. In the year, more than 8000 patients were treated with hemangioma, and more than 400 patients with differentiated thyroid cancer were treated with bone metastases, radioactive particle implantation and radioimmunoassay. The radionuclide ward is equipped with two automatic radionuclide packers and 14 open beds. The new modern nuclide ward will be put into operation in late 2014.
The in vitro molecular detection group has 3 parts: the Abbott Company, Roche's fully automated light immunoassay system. More than 40 standardized tests were carried out for thyroid kinetic energy, parathyroid function, pituitary gonadal function, adrenal function, viral hepatitis and tumor markers. The results were fast and accurate, which were the only one in the laboratory of the clinical laboratory center of the Ministry of health. The newly developed urinary iodine test is an important indicator reflecting the level of iodine nutrition in human body, which enriches the diagnostic means of thyroid diseases.
